US 7,351,698 B2
	Androgen receptor modulators and methods of use thereof
Robert S. Meissner, Schwenksville, Pa. (US); and James J. Perkins, Churchville, Pa. (US)
Assigned to Merck & Co., Inc., Rahway, N.J. (US)
Appl. No. 10/551,975 PCT Filed May 03, 2004, PCT No. PCT/US2004/013787 § 371(c)(1), (2), (4) Date Oct. 05, 2005, PCT Pub. No. WO2004/100874, PCT Pub. Date Nov. 25, 2004.
Claims priority of provisional application 60/468579, filed on May 07, 2003.
Prior Publication US 2006/0241107 A1, Oct. 26, 2006
Int. Cl. A01N 57/00 (2006.01); A01N 43/42 (2006.01); A61K 31/675 (2006.01); A61K 31/44 (2006.01)

U.S. Cl. 514—80  [514/284; 546/23; 546/77]

1 Claim

1. A compound according which is 4-methyl-17β-[(4-trifluoromethylphenyl)acetamido-4-aza-5α-androst-1-ene-3-one; or a pharmaceutically acceptable salt thereof.